Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Minh Patrick Lê
Reply To: “Therapeutic Drug Monitoring for Sofosbuvir and Daclatasvir in Transplant Recipients With Chronic Hepatitis C and Advanced Renal Disease”
Journal of Hepatology
Hepatology
Lack of a Clinically Significant Pharmacokinetic Interaction Between Etravirine and Raltegravir Using an Original Approach Based on Drug Metabolism, Protein Binding, and Penetration in Seminal Fluid: A Pharmacokinetic Substudy of the ANRS-163 ETRAL Study
Pharmacotherapy
Pharmacology
Related publications
A Prospective Study of Daclatasvir and Sofosbuvir in Chronic HCV-infected Kidney Transplant Recipients
BMC Nephrology
Nephrology
Sofosbuvir Plus Ledipasvir for Recurrent Hepatitis C in Liver Transplant Recipients
Liver Transplantation
Hepatology
Transplantation
Surgery
Secondary Occult Hepatitis C Virus Infection (HCV) in Chronic HCV Patients After Treatment With Sofosbuvir and Daclatasvir
International Journal of Current Microbiology and Applied Sciences
The Effectiveness of Daclatasvir Based Therapy in European Patients With Chronic Hepatitis C and Advanced Liver Disease
BMC Infectious Diseases
Infectious Diseases
Kidney Transplant Recipients With Hepatitis C Virus Experienced 100% SVR12 Rate When Treated With Sofosbuvir-Ledipasvir
Hepatology
Medicine
Hepatology
Daclatasvir and Sofosbuvir Therapy Enhance Monocyte Phenotypic Changes in Naive Chronic Hepatitis C Patients: A Prospective Cohort Study
Interdisciplinary Perspectives on Infectious Diseases
Virology
Parasitology
Infectious Diseases
Microbiology
Daclatasvir and Sofosbuvir With Ribavirin for 24 Weeks in Chronic Hepatitis C Genotype-3-Infected Patients With Cirrhosis: A Phase III Study (ALLY-3C)
Antiviral Therapy
Infectious Diseases
Pharmacology
Treatment of Chronic Hepatitis C Virus in Allogeneic Bone Marrow Transplant Recipients
Bone Marrow Transplantation
Transplantation
Hematology
Sofosbuvir Plus Daclatasvir With or Without Ribavirin in 551 Patients With Hepatitis C-Related Cirrhosis, Genotype 4
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology